Found 18 matching trials
Genotype Guided Antiplatelet Therapy In Ischemic Stroke
NAA fifth of ischemic stroke or transient ischemic attack (TIA) patients will...
Status
Active Not Recruiting
Location
Singapore General Hospital
Cost-effectiveness of Genotype Guided Treatment With Antiplatelet Drugs in STEMI Patients: Optimization of Treatment (POPular Genetics)
PHASE4Rationale: the use of antiplatelet drugs (i.e. clopidogrel, ticagrelor or p...
Impact of CYP2C19 Genotype-guided Approach in Antiplatelet Therapy on Platelet Reactivity Index Among Coronary Artery Disease (CAD) Patients
PHASE4The goal of this clinical trial is to learn if the pilot intervention of CY...
Location
Hospital Pakar Universiti Sains Malaysia
CYP2C19 Genotype-Guided P2Y12 Receptor Inhibitor Selection After Complex Percutaneous Coronary Intervention
PHASE4In Ease Asia clinical trials, P2Y12 inhibitor (ticagrelor or clopidogrel) m...
Location
Affiliated Hospital of Zunyi Medical University
Reduced Antithrombotic Strategy for High Bleeding Risk Patients With Myocardial Infarction
PHASE4Rationale: Heart attacks are a major cause of death and result from coronar...
Location
Aalborg University Hospital
Genotype-Guided Abbreviated DAPT Versus Un-Guided De-escalation Therapy in Patients With ACS and HBR
PHASE4The aim of this study is to assess the safety and efficacy of the CYP2C19 g...
Location
Samsung Medical Center
Effect of Genotype-Guided Oral P2Y12 Inhibitor Selection vs Conventional Clopidogrel Therapy in Symptomatic ICAD
NAStroke is an important cause of death, disability, and memory problems in a...
Location
University of Calgary
Impact of CYP2C19 Genotype-guided Clopidogrel and Ticagrelor Treatment on Platelet Function Test and Metabolomics Profile
PHASE4Several studies have shown that pharmacodynamic (PD) response varies betwee...
Location
Department of Cardiology, Penang General Hospital
Tailored Antiplatelet Therapy Following PCI
PHASE4Clopidogrel is an anti-platelet medication approved by the U.S. Federal Dru...
Location
Mayo Clinic in Arizona
Evaluating Pharmacogenomic Variants for Cardiology Therapeutics
NACipherome's Lighthouse is a clinical decision support tool that incorporate...
Location
Doctors Hospital at Renaissance